Navigation Links
NxStage Patient Takes Dialysis Machine on Third Annual Patient Good-Will Tour

LAWRENCE, Mass., Sept. 18 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that home dialysis patient Harvey Wells, 57, has embarked on his third annual "Grandpa's Road Trip" with the NxStage(R) System One(TM). As a portable home hemodialysis machine, the NxStage System One provides Mr. Wells the opportunity to fit hemodialysis therapy into his own lifestyle and schedule. Mr. Wells is once again celebrating this freedom by traveling the country in his RV and sharing with other patients his experience doing home daily hemodialysis with the NxStage System One.

"NxStage was founded to improve the lives of dialysis patients, like Harvey, by providing them the freedom to dialyze when they want and where they want," said Jeffrey H. Burbank, chief executive officer of NxStage Medical. "Harvey is an inspiration to all of us at NxStage. He also shares our belief that, although home hemodialysis is not for everyone, there are many patients who can benefit from the reported health and quality of life benefits of more frequent home dialysis."

Mr. Wells' "Grandpa's Road Trip 2009: The Football Tour" began on Sunday, September 13, 2009 in Cleveland. During the tour, Mr. Wells will also be attending football games in Denver, Baltimore, Buffalo, Pittsburgh, Chicago, Detroit, Cincinnati, and Kansas City, and spending several days at local dialysis centers in each city meeting with kidney patients and educating them about home hemodialysis. The 2009 Road Trip will run through the end of regular season football on January 3, 2010.

Mr. Wells was first diagnosed with reduced kidney function at the age of 18. Following a failed kidney transplant, Mr. Wells began four and a half hour dialysis sessions at a treatment center three days a week in 2006. These treatments often left him fatigued and made traveling difficult. Now, as a NxStage System One patient, Mr. Wells dialyzes on a more frequent basis and travels with his family.

In 2007, Mr. Wells and his wife took their two grandsons on a two-week road trip in his RV with the NxStage System One, spanning 3,700 miles and 11 states. In the summer of 2008, Mr. Wells expanded his tour to a 51-day excursion covering more than 12,500 miles and 37 states. Along the way, he dialyzed with a partner in his RV using the System One and visited 22 dialysis centers to speak to kidney patients about home hemodialysis.

"I'm excited to be able to share my love of football with my grandsons and make stops at dialysis centers between games," Wells said. "I am passionate about what this small, portable hemodialysis machine has done for me and the freedom it has given me and my family to travel together all over this country."

The NxStage System One is the first truly portable hemodialysis system cleared for home use by the U.S. Food & Drug Administration (FDA). Its simplicity and compact size are intended to allow ease of use and to give patients the opportunity to travel with their therapy with their doctor's approval. It plugs into standard electrical outlets and, unlike conventional hemodialysis systems, requires no special infrastructure to operate. Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs, at home or on vacation.

Follow Harvey Wells on his 2009 "Grandpa's Road Trip" on the NxStage website (

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of End Stage Renal Disease (ESRD) and acute kidney failure. For more information on NxStage and its products, please visit NxStage's website at


Mr. Wells receives a speaking engagement fee from NxStage for each RV tour dialysis center stop and reimbursement for travel expenses directly related to his dialysis center stops. Mr. Wells covers all other expenses.

    Investor Relations Contact
    Kristen Sheppard
    NxStage Medical, Inc.

    Media Contact
    Jim Weinrebe
    Schwartz Communications, Inc.

SOURCE NxStage Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NxStage Medical Completes Acquisition of Medisystems
2. NxStage Medical Reports Third Quarter 2007 Results
3. NxStage Medical Establishes $50 Million Credit Facility with a Group of Lenders Led by Merrill Lynch Capital
4. NxStage(R) Medical to Report Fourth Quarter & Full Year 2007 Financial Results on Tuesday, February 12th
5. NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 2008
6. NxStage Medical Reports Fourth Quarter and Full Year 2007 Results
7. Emil Paganini, MD, Joins NxStage(R) as Critical Care Medical Advisor
8. Tsongas Visits Lawrence-based Medical Device Maker NxStage Medical, Inc.
9. NxStage Announces Supply Agreement With Kawasumi Laboratories for Blood Tubing Sets
10. NxStage Medical Reports First Quarter 2008 Results
11. NxStage Announces $43 Million Private Placement of Equity Securities
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from reveals that behind the tendency to set low expectations ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
Breaking Medicine Technology: